Hypoxia and human genome stability: downregulation of BRCA2 expression in breast cancer cell lines

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Hypoxia is known to increase mutagenesis and alter DNA repair.
• Previous studies linked hypoxia to decreased BRCA1 expression and homologous recombination suppression, causing genetic instability.
• The role of BRCA2 in breast cancer under hypoxic conditions remains largely unknown.

Purpose of the Study:

• To investigate the effect of hypoxia on breast cancer cell proliferation.
• To analyze gene expression changes in breast cancer cells under hypoxia.
• To determine the specific role of BRCA2 in breast cancer under hypoxic conditions.

Main Methods:

• Cell proliferation assays were performed to assess short-term effects of hypoxia.
• Microarray analysis was used to examine gene expression in hypoxic breast cancer cell lines.
• BRCA2 downregulation was confirmed at both mRNA and protein levels.
• Cells were treated with dimethyloxalylglycine (DMOG) to stabilize HIF-1α in normoxia.

Main Results:

• Hypoxia was found to negatively regulate breast cancer cell growth in vitro.
• Genes involved in DNA damage repair pathways, including mismatch repair, nucleotide excision repair, nonhomologous end-joining, and homologous recombination repair, were downregulated.
• BRCA2 downregulation was observed at both mRNA and protein levels under hypoxic conditions.
• DMOG treatment yielded results comparable to hypoxia, confirming HIF-1α stabilization's role.

Conclusions:

• Hypoxia negatively impacts breast cancer cell proliferation.
• Hypoxia induces downregulation of key DNA repair pathways, including those involving BRCA2.
• BRCA2 downregulation under hypoxia may contribute to genetic instability in sporadic breast cancers.
• These findings offer new insights into hypoxia-mediated genetic instability and BRCA involvement in breast cancer.